Latest News

Expiration of enhanced ACA subsidies threatens to increase premiums 75% and reduce marketplace enrollment by millions.

340B program expansion drains billions from state Medicaid budgets while failing to deliver promised drug cost savings.

Pharmacy benefit managers extract billions while adding no value, increasing costs without improving patient access or health outcomes.

Copay accumulator programs exclude patient assistance from deductibles, creating barriers to medication adherence and treatment.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

FTC enforcement against hospital mergers and implications for costs and access.

Rising medical debt burden among insured Americans and systemic causes.

Healthcare workforce understaffing driven by profit maximization and consolidation.

CMS's $9B remedy to hospitals after SCOTUS 340B ruling lacks enforcement of charitable care requirements.

Hospital price transparency and 340B lack accountability while patients face medical debt.

Biden's SOTU addresses harm reduction, endorses MAT Act; limited HIV-specific programming focus.

Analyzes CMS marketplace rule changes and Medicaid expansion risks as pandemic emergency declarations end.

Examines CMS's rebate rule on copay accumulator programs that block patient assistance from counting toward deductibles.